Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status-Reference-Cited by-同舟云学术

Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status

Published:2004-04 Issue:4 Volume:60 Page:476-483
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Mukherjee A.,Murray R. D.,Teasdale G. M.,Shalet S. M.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2004.02004.x/fullpdf

Reference42 articles.

1. Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain

2. The treatment of Cushing's syndrome

3. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects

4. Two Unusual Variants of Nelson's Syndrome*

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropsychological complications of hypoprolactinemia;Reviews in Endocrine and Metabolic Disorders;2024-07-03

2. Evidence‐based management strategies for endocrine complications after pituitary adenoma surgery;Ibrain;2024-05-23

3. Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease;Pituitary;2022-05-13

4. Growth hormone deficiency in adults with Cushing's disease;Best Practice & Research Clinical Endocrinology & Metabolism;2021-03

5. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline;The Journal of Clinical Endocrinology & Metabolism;2015-08